Literature DB >> 29862173

Transfection with CXCR4 potentiates homing of mesenchymal stem cells in vitro and therapy of diabetic retinopathy in vivo.

Jian Wang1, Wei Zhang1, Guang-Hui He1, Bin Wu1, Song Chen1.   

Abstract

AIM: To investigate the effect of the overexpression of C-X-C chemokine receptor type 4 (CXCR4) on homing of mesenchymal stem cells (MSCs) in vitro and therapeutic effects of diabetic retinopathy (DR) in vivo.
METHODS: MSCs were infected by lentivirus constructed with CXCR4. The expression of CXCR4 was examined by immunofluorescence, Western blot, and quantitative polymerase chain reaction. CXCR4-overexpressing MSCs were cultured in vitro to evaluate their chemotaxis, migration, and apoptotic activities. CXCR4-overexpressing MSCs were intravitreally injected to observe and compare their effects in a mouse model of DR. The histological structure of DR in rats was inspected by hematoxylin and eosin staining. The expression of rhodopsin, neuron-specific enolase (NSE), and inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α was examined by Western blot and immunohistochemical analyses.
RESULTS: The transduction of MSCs by lentivirus was effective, and the transduced MSCs had high expression levels of CXCR4 gene and protein. Improved migration activities were observed in CXCR4-overexpressing MSCs. Further, reduced retinal damage, upregulation of rhodopsin and NSE protein, and downregulation of inflammatory cytokines IL-6 and TNF-α were observed in CXCR4-overexpressing MSCs in vivo.
CONCLUSION: The homing of MSCs can be enhanced by upregulating CXCR4 levels, possibly improving histological structures of DR. CXCR4-overexpressing MSCs can be a novel strategy for treating DR.

Entities:  

Keywords:  chemokine receptor type 4; diabetic retinopathy; mesenchymal stem cells; transplantation

Year:  2018        PMID: 29862173      PMCID: PMC5957026          DOI: 10.18240/ijo.2018.05.08

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

Review 1.  UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.

Authors:  Kenneth W Douglas; Maria Gilleece; Patrick Hayden; Hannah Hunter; Peter R E Johnson; Charlotte Kallmeyer; Ram K Malladi; Shankara Paneesha; Rachel Pawson; Michael Quinn; Kavita Raj; Deborah Richardson; Stephen Robinson; Nigel Russell; John Snowden; Anna Sureda; Eleni Tholouli; Kirsty Thomson; Mike Watts; Keith M Wilson
Journal:  J Clin Apher       Date:  2017-06-20       Impact factor: 2.821

2.  Micro-vesicles derived from bone marrow stem cells protect the kidney both in vivo and in vitro by microRNA-dependent repairing.

Authors:  Juan He; Yan Wang; Xingyan Lu; Bei Zhu; Xiaohua Pei; Jianqing Wu; Weihong Zhao
Journal:  Nephrology (Carlton)       Date:  2015-09       Impact factor: 2.506

3.  Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy.

Authors:  Wenchao Hu; Rui Wang; Jun Li; Jie Zhang; Wenhui Wang
Journal:  Ann Clin Biochem       Date:  2015-03-26       Impact factor: 2.057

Review 4.  Coming into focus: the role of extracellular matrix in vertebrate optic cup morphogenesis.

Authors:  Kristen M Kwan
Journal:  Dev Dyn       Date:  2014-07-19       Impact factor: 3.780

Review 5.  Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.

Authors:  Lun Kelvin Tsou; Ying-Huey Huang; Jen-Shin Song; Yi-Yu Ke; Jing-Kai Huang; Kak-Shan Shia
Journal:  Med Res Rev       Date:  2017-08-02       Impact factor: 12.944

6.  CXCR4 (CD184) expression on stem cell harvest and CD34+ cells post-transplant.

Authors:  Inas Asfour; Hanaa Afify; Shaza Elkourashy; Maryse Ayoub; Gihan Kamal; Mary Gamal; Ghada Elgohary
Journal:  Hematol Oncol Stem Cell Ther       Date:  2017-03-02

7.  Dysfunction of circulating endothelial progenitor cells in type 1 diabetic rats with diabetic retinopathy.

Authors:  Wei Zhang; Hua Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-06       Impact factor: 3.117

8.  Microparticle levels after arterial injury and NO therapy in diabetes.

Authors:  Zheng Wang; Zachary M Emond; Megan E Flynn; Suchitra Swaminathan; Melina R Kibbe
Journal:  J Surg Res       Date:  2015-09-05       Impact factor: 2.192

9.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

10.  Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells.

Authors:  Sandra Atienzar-Aroca; Miguel Flores-Bellver; Gemma Serrano-Heras; Natalia Martinez-Gil; Jorge M Barcia; Silvia Aparicio; Daniel Perez-Cremades; Jose M Garcia-Verdugo; Manuel Diaz-Llopis; Francisco J Romero; Javier Sancho-Pelluz
Journal:  J Cell Mol Med       Date:  2016-03-21       Impact factor: 5.310

View more
  5 in total

1.  Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.

Authors:  W Li; L Jin; Y Cui; A Nie; N Xie; G Liang
Journal:  J Endocrinol Invest       Date:  2020-09-26       Impact factor: 4.256

2.  Mesenchymal Stem/Stromal Cells Overexpressing CXCR4R334X Revealed Enhanced Migration: A Lesson Learned from the Pathogenesis of WHIM Syndrome.

Authors:  Hamid Reza Bidkhori; Ahmad Reza Bahrami; Moein Farshchian; Asieh Heirani-Tabasi; Mahdi Mirahmadi; Halimeh Hasanzadeh; Naghmeh Ahmadiankia; Reza Faridhosseini; Mahtab Dastpak; Arezoo Gowhari Shabgah; Maryam M Matin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 3.  Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina.

Authors:  Judith Lechner; Reinhold J Medina; Noemi Lois; Alan W Stitt
Journal:  Stem Cell Res Ther       Date:  2022-07-30       Impact factor: 8.079

Review 4.  Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases.

Authors:  Giuliana Mannino; Cristina Russo; Anna Longo; Carmelina Daniela Anfuso; Gabriella Lupo; Debora Lo Furno; Rosario Giuffrida; Giovanni Giurdanella
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

Review 5.  Stem Cell Therapy for Retinal Degeneration: The Evidence to Date.

Authors:  Amit Sharma; Bithiah Grace Jaganathan
Journal:  Biologics       Date:  2021-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.